Note: Ingredients listed on restricted chemical lists
EC/CAS
918-668-5/64742-95-6
Name of the chemical
Solvent naphtha (petroleum), light arom
Concentration
5-<10
General Information
Version
1.02
Revision date
2019-03-04
Product name
SIGMA PLUS RAL 7035 DRH
1.2.1 Relevant identified uses
Industrial applications
Emergency telephone
+7 (4742) 42-30-00, +7 (4742)...
Icons in SDS
Company Information
company name
Limited Liability Company ‘PPG Industries
e-mail address of the competent person responsible for the Safety Data Sheet
RusMsdsContact@ppg.com
GHS Information
Signal word
Warning
Hazard Codes
Hazard statements (CLP)
H226, H412
Hazard statements
Code
Statements
H226
Flammable liquid and vapour
Section 2
SECTION 2: Hazards identification
1272/2008] Classification of the substance or mixture
Product definition
Mixture
Signal word
Warning
Hazard statements
Flammable liquid and vapour. Harmful to aquatic life with long lasting effects.
Prevention
Wear protective gloves. Wear protective clothing. Wear eye or face protection. Keep away from heat, hot surfaces, sparks, open flames and other ignition sources. No smoking.
Response
IF ON SKIN (or hair): Take off immediately all contaminated clothing. Rinse skin with water.
Storage
Store in a well-ventilated place. Keep cool.
Disposal
Not applicable.
Hazardous Ingredients
Not applicable.
Supplemental label elements
Not applicable.
Annex XVII - Restrictions on the manufacture, placing on the market and use of certain dangerous substances, mixtures and articles
Not applicable.
Special packaging requirements
Containers to be fitted with child-resistant fastenings : Not applicable.
Tactile warning of danger
Not applicable.
Other hazards which do not result in classification
Prolonged or repeated contact may dry skin and cause irritation.
2.1 Classification of the substance or mixture
Product definition : Mixture Classification according to Regulation (EC) No. 1272/2008 [CLP/GHS] Flam. Liq. 3, H226 Aquatic Chronic 3, H412 The product is classified as hazardous according to Regulation (EC) 1272/2008 as amended. See Section 16 for the full text of the H statements declared above. See Section 11 for more detailed information on health effects and symptoms.
